Mirum Pharmaceuticals, Inc.

Q4 2023 13F Holders

Symbol
MIRM
CUSIP
604749101
Type
Equity
Class
COM
Num filings
203
Total reported value, excl. options
$1.53 B
Manager Report Date Value ($000) Shares Option Type